MedPath
FDA Approval

Carbidopa and Levodopa

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
May 8, 2019
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Carbidopa(25 mg in 1 1)
Levodopa(100 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Aphena Pharma Solutions - Tennessee, LLC

Aphena Pharma Solutions - Tennessee, LLC

128385585

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Carbidopa and Levodopa

Product Details

NDC Product Code
71610-269
Application Number
ANDA073589
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 4, 2019
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3GClass: IACT
CarbidopaActive
Code: MNX7R8C5VOClass: ACTIMQuantity: 25 mg in 1 1
LevodopaActive
Code: 46627O600JClass: ACTIBQuantity: 100 mg in 1 1
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8Class: IACT
© Copyright 2025. All Rights Reserved by MedPath